Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2663055 | 0.84 | GCGR (0.71) | GCGR | |
| SCHEMBL8949822 | 0.83 | GCGR (0.88) | GCGR | |
| SCHEMBL8878602 | 0.82 | GCGR (0.64) | GCGR | |
| SCHEMBL14544897 | 0.81 | GCGR (0.44) | GCGRPRKAA2 | |
| SCHEMBL8879678 | 0.81 | GCGR (0.62) | GCGR | |
| SCHEMBL6958030 | 0.80 | GCGR (0.72) | GCGR | |
| SCHEMBL10475261 | 0.80 | PRKAA2 (0.66) | GCGRPRKAA2 | |
| SCHEMBL2649028 | 0.80 | GCGR (0.73) | GCGR | |
| SCHEMBL8876905 | 0.80 | GCGR (0.76) | GCGR | |
| SCHEMBL8876815 | 0.80 | GCGR (0.61) | GCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5872130-A | ANTI-HYPERLIPIDEMIC, HYPOLIPOPROTEINEMIC AND ANTI-ATHEROSCLEROTIC AGENTS | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1999-02-16 | — | — | US | disclosed |
| US-5856336-A | Quinoline type mevalonolactones | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1999-01-05 | — | — | US | disclosed |
| US-5854259-A | Quinoline type mevalonolactones | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1998-12-29 | — | — | US | disclosed |
| US-5691322-A | Quinoline and pyridine anchors for HMG-CoA reductase inhibitors | E.R. SQUIBB & SONS, INC. (US) | 1997-11-25 | — | — | US | disclosed |
| US-5686433-A | CHOLESTEROL BIOSYNTHESIS INHIBITION | E.R. SQUIBB & SONS, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| US-5506219-A | ANTICHOLESTEROL AND ANTILIPEMIC AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1996-04-09 | — | — | US | disclosed |
| EP-0304063-B1 | Quinoline type mevalonolactones | NISSAN CHEMICAL IND LTD (JP) | 1994-11-30 | — | — | EP | disclosed |
| US-5185328-A | Hydroxy-3-methylglutaryl/3-/ coenzyme A reductase inhibitors | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-02-09 | — | — | US | disclosed |
| US-5102888-A | QUINOLINE TYPE MEVALONOLACTONES USEFUL FOR TREATING HYPERLIPIDEMIA AND RELATED DISEASES | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-04-07 | — | — | US | disclosed |
| US-5011930-A | Antilipemic agents, anticoagulants | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1991-04-30 | — | — | US | disclosed |
| EP-0356788-A2 | Quinoline and pyridine anchors for HMG-CoA reductase inhibitors | E.R. SQUIBB & SONS, INC. (US) | 1990-03-07 | — | — | EP | disclosed |
| EP-0304063-A2 | Quinoline type mevalonolactones | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1989-02-22 | — | — | EP | disclosed |